Pharma Foods International Co., Ltd. (TYO:2929)
703.00
+20.00 (2.93%)
At close: Mar 27, 2026
TYO:2929 Revenue
Pharma Foods International had revenue of 16.73B JPY in the quarter ending January 31, 2026, with 9.62% growth. This brings the company's revenue in the last twelve months to 67.84B, up 12.41% year-over-year. In the fiscal year ending July 31, 2025, Pharma Foods International had annual revenue of 65.26B with 5.01% growth.
Revenue (ttm)
67.84B
Revenue Growth
+12.41%
P/S Ratio
0.30
Revenue / Employee
110.68M
Employees
613
Market Cap
20.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | 65.26B | 3.11B | 5.01% |
| Jul 31, 2024 | 62.15B | -6.43B | -9.37% |
| Jul 31, 2023 | 68.57B | 8.39B | 13.94% |
| Jul 31, 2022 | 60.19B | 13.43B | 28.73% |
| Jul 31, 2021 | 46.75B | 31.40B | 204.51% |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Fuso Pharmaceutical Industries,Ltd. | 62.17B |
| Daito Pharmaceutical | 51.20B |
| Koa Shoji Holdings | 23.66B |
| Morishita Jintan | 12.87B |
| Mizuho Medy | 11.26B |
| Wakamoto Pharmaceutical | 9.43B |
| Taiko Pharmaceutical | 6.40B |
| WDB coco | 4.98B |